The mitochondria-targeted nitroxide JP4-039 augments potentially lethal irradiation damage repair.

It was unknown if a mitochondria-targeted nitroxide (JP4-039) could augment potentially lethal damage repair (PLDR) of cells in quiescence. We evaluated 32D cl 3 murine hematopoietic progenitor cells which were irradiated and then either centrifuged to pellets (to simulate PLDR conditions) or left in exponential growth for 0, 24, 48 or 72 h. Pelleted cells demonstrated cell cycle arrest with a greater percentage in the G(1)-phase than did exponentially growing cells. Irradiation survival curves demonstrated a significant radiation damage mitigation effect of JP4-039 over untreated cells in cells pelleted for 24 h. No significant radiation mitigation was detected if drugs were added 48 or 72 h after irradiation. Electron paramagnetic resonance spectroscopy demonstrated a greater concentration of JP4-039 in mitochondria of 24 h-pelleted cells than in exponentially growing cells. These results establish a potential role of mitochondria-targeted nitroxide drugs as mitigators of radiation damage to quiescent cells including stem cells.

[1]  P. Wipf,et al.  The Mitochondrial Targeted GS-Nitroxide JP4-039 is Radioprotective In Vitro and In Vivo , 2008 .

[2]  J. Haveman,et al.  G0 Cell Cycle Arrest Alone is Insufficient for Enabling the Repair of Ionizing Radiation-Induced Potentially Lethal Damage , 2008, Radiation research.

[3]  P. Wipf,et al.  A mitochondria-targeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation. , 2008, International journal of radiation oncology, biology, physics.

[4]  P. Wipf,et al.  Targeting mitochondria. , 2008, Accounts of chemical research.

[5]  J. Greenberger.  Gene therapy approaches for stem cell protection , 2008, Gene Therapy.

[6]  C. Macias,et al.  Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted anti-oxidants. , 2007, Biochemical pharmacology.

[7]  James B. Mitchell,et al.  The chemistry and biology of nitroxide compounds. , 2007, Free radical biology & medicine.

[8]  D. Scadden,et al.  The hematopoietic stem cell in its place , 2006, Nature Immunology.

[9]  P. Wipf,et al.  Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. , 2005, Journal of the American Chemical Society.

[10]  Yu-fang Cui,et al.  Pathways to caspase activation , 2005, Cell biology international.

[11]  Keisuke Ito,et al.  Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.

[12]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[13]  J. Greenberger,et al.  Mitochondrial Localization of Superoxide Dismutase is Required for Decreasing Radiation-Induced Cellular Damage , 2003, Radiation research.

[14]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[15]  P. Kochanek,et al.  Antioxidant Tempol Enhances Hypothermic Cerebral Preservation during Prolonged Cardiac Arrest in Dogs , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  A. Kanai,et al.  Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Barendsen,et al.  Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments (review). , 2001, International journal of oncology.

[18]  G. Margison,et al.  O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells. , 2001, Experimental hematology.

[19]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[20]  E. Prochownik,et al.  Biology of marrow stromal cell lines derived from long-term bone marrow cultures of Trp53-deficient mice. , 1999, Radiation research.

[21]  J. Greenberger,et al.  Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy , 1998, Gene Therapy.

[22]  R. Hodges,et al.  Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity. , 1997, Biochemistry.

[23]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[24]  I. Weissman,et al.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.

[25]  I. Weissman,et al.  Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells , 1993, The Journal of cell biology.

[26]  S. Hahn,et al.  Tempol, a stable free radical, is a novel murine radiation protector. , 1992, Cancer research.

[27]  J. Hendry,et al.  Clonogen number and radiosensitivity in rat thyroid follicles. , 1991, Radiation research.

[28]  S. Hahn,et al.  Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. , 1991, Archives of biochemistry and biophysics.

[29]  G. Iliakis.  Radiation-induced potentially lethal damage: DNA lesions susceptible to fixation. , 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[30]  M. Frankenberg-Schwager,et al.  Potentially lethal damage repair is due to the difference of DNA double-strand break repair under immediate and delayed plating conditions. , 1987, Radiation research.

[31]  G. Michalopoulos,et al.  The survival of parenchymal hepatocytes irradiated with low and high LET radiation. , 1984, The British journal of cancer. Supplement.

[32]  P. Deschavanne,et al.  Repair of sublethal and potentially lethal damage in lung cells using an in vitro colony method. , 1981, The British journal of radiology.

[33]  R. Mulcahy,et al.  The survival of thyroid cells: in vivo irradiation and in situ repair. , 1980, Radiation research.

[34]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[35]  J. Little.  Factors influencing the repair of potentially lethal radiation damage in growth-inhibited human cells. , 1973, Radiation research.

[36]  W. Dewey,et al.  Repair of sublethal and potentially lethal x-ray damage in synchronous Chinese hamster cells. , 1972, Radiation research.

[37]  J. Little.  Repair of Sub-lethal and Potentially Lethal Radiation Damage in Plateau Phase Cultures of Human Cells , 1969, Nature.

[38]  J. Belli,et al.  Potentially Lethal Radiation Damage: Repair by Mammalian Cells in Culture , 1969, Science.

[39]  L. Tolmach,et al.  Modification of x-ray-induced killing of HeLa S3 cells by inhibitors of DNA synthesis. , 1967, Biophysical journal.

[40]  G. Whitmore,et al.  Studies on recovery processes in mouse L cells. , 1967, National Cancer Institute monograph.

[41]  L. Tolmach,et al.  Repair of potentially lethal damage in x-irradiated HeLa cells. , 1966, Radiation research.

[42]  L. Tolmach,et al.  X-Ray Sensitivity and DNA Synthesis in Synchronous Populations of HeLa Cells , 1963, Science.